Login / Signup

Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma.

Daniel A RauchSydney L OlsonJohn C HardingHemalatha SundaramoorthiYoungsoo KimTianyuan ZhouA Robert MacLeodGrant ChallenLee Ratner
Published in: Retrovirology (2020)
These data support the pursuit of IRF4 as a therapeutic target in ATLL with the use of either ASOs or lenalidomide.
Keyphrases